Blackstone’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Blackstone's RPRX Position: Q3 2026 in Review
Blackstone opened a new position in Royalty Pharma (RPRX) in Q3 2026: 14,444 shares worth $843K. The stake represents ﹤0.01% of the portfolio and ranks #246 among its holdings. This is a return to the name: Blackstone previously reported a position in RPRX as recently as Q3 2020.
Blackstone first reported a position in RPRX in Q2 2020 and has held it in 3 quarters since. The position peaked at $15.3M in Q3 2020. 697 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Blackstone held 14,444 shares of Royalty Pharma worth $843K as of Q3 2026.
- Royalty Pharma was a new Blackstone position in Q3 2026.
- Royalty Pharma made up ﹤0.01% of Blackstone's portfolio in Q3 2026, its #246 holding.
- Blackstone first reported a position in Royalty Pharma in Q2 2020 and has held it in 3 quarters since.
- Blackstone's Royalty Pharma position peaked at $15.3M in Q3 2020.
- 697 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.